CARGO Therapeutics, Inc.
DelistedCIK 1966494fmd_04DYJ66AXC5QFK71NE9XDP6BWJManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2022 to Jun 30, 2025, 14 periods
| Line item | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Research and development | 29 | 76 | 143 |
| Total operating expenses | 35 | 97 | 187 |
| Operating income | (35) | (97) | (187) |
| Interest expense | 5 | 2 | 0 |
| Interest and investment income | – | 5 | 20 |
| Other non-operating income (expense) | (0) | (0) | (0) |
| Net income | (41) | (98) | (168) |